Infliximab dependency in a national cohort of children with Crohn's disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 42, Issue 1, 2006, Pages 40-45

  Wewer, Vibeke ^a   Riis, Lene ^b   Vind, Ida ^a   Husby, Steffen ^c   Munkholm, Pia ^b   Paerregaard, Anders ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adolescent; Children; Crohn's disease; Dependency; Infliximab; Pattern recognition; Responsiveness

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; METHOTREXATE;

ADOLESCENT; ADULT; ANAPHYLAXIS; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CROHN DISEASE; DENMARK; DISEASE COURSE; DISEASE DURATION; DRUG INFUSION; DRUG MONITORING; FEMALE; HERPES ZOSTER; HUMAN; MALE; PEDIATRIC WARD; PRIORITY JOURNAL; RELAPSE; SCHOOL CHILD; SERUM SICKNESS; TREATMENT INDICATION; TREATMENT RESPONSE;

ADOLESCENT; ANTIBODIES, MONOCLONAL; CHILD; COHORT STUDIES; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

HERPES ZOSTER;

EID: 30344431805     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000189137.06151.33     Document Type: Article

References (21)

1. Escher JC, Taminiau JA, Nieuwenhuis EE, et al. Treatment of inflammatory bowel disease in childhood: best available evidence. Inflamm Bowel Dis 2003;9:34-58.
2. Griffith AM, Wesson DE, Shandling B, et al. Factors influencing postoperative recurrence of Crohn's disease in childhood. Gut 1991;32:491-5.
3. Langholz E, Munkholm P, Krasilnikoff PA, Binder V. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997;32:139-47.
4. Munkholm P, Langholz E, Davidsen B, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995;30:699-706.
5. Munkholm P. Crohn's disease: occurrence, course and prognosis. Danish Med Bull 1997;44:287-302.
6. Targan SR, Hanauer SB, Van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumour necrosing factor α for Crohn's disease. N Engl J Med 1997;337:1029-35.
7. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance Infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359:1541-9.
8. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405.
9. Lionetti P, Bronzini F, Salvestrini C, et al. Response to infliximab is related to disease duration in paediatric Crohn's disease. Aliment Pharmacol Ther 2003;18:425-31.
10. Cezard JP, Nouaili N, Talbotec C, et al. A prospective study of the efficacy and tolerance of a chimeric antibody to tumour necrosis factors (Remicade) in severe paediatric Crohn's disease. J Pediatr Gastroenterol Nutr 2003;36:632-6.
11. Borrelli O, Bascietto C, Viola F, et al. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig Liver Dis 2004;36:342-7.
12. de Ridder L, Escher JC, Bouquet J, et al. Infliximab in 30 patients with refractory pediatric Crohn disease with and without fistulas in the Netherlands. J Pediatr Gastroenterol Nutr 2004;39:46-52.
13. Baldassano RB, Braegger CP, Escher JC, et al. Infliximab (Remicade) therapy in the treatment of pediatric Crohn's disease. Am J Gastroenterol 2003;98:833-8.
14. Stephens MC, Shepanski MS, Mamula P, et al. Safety and steroid sparring experience using infliximab for Crohn's disease at a paediatric inflammatory disease centre. Am J Gastroenterol 2003;98:104-11.
15. Friesen CA, Calabro C, Christenson K, et al. Safety of infliximab in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2004;39:265-9.
16. Munkholm P, Langholz E, Davidsen M, et al. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994;35:360-2.
17. Faubion WA, Loftus EV, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001;121:255-60.
18. Vind I, Riis L, Wewer V, et al. Infliximab dependency and resistance in Crohn's disease. Infliximab dependency and resistance in Crohn's disease. Gut 2002;51(Suppl III):A325.
19. Munkholm P. Crohn's Disease: occurrence, course and prognosis. Danish Med Bull 1997;44:27-302.
20. Crandall WV, Mackner LM. Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model. Aliment Pharmacol Ther 2003;17:75-84.
21. Nikolaus S, Raedler A, Kühbacher T, et al. Mechanism in failure of infliximab for Crohn's disease. Lancet 2000;356:1475-9.